John Mendlein's Net Worth
$928 Thousand
Who is John Mendlein?
John Mendlein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Moderna, Inc., Omega Therapeutics, Inc., Editas Medicine, Inc., FATE THERAPEUTICS INC, aTYR PHARMA INC, VIROLOGIC INC, and ACLARA BIOSCIENCES INC.
SEC CIK
John Mendlein's CIK is 0001238362
Past Insider Trading and Trends
2017 was John Mendlein's most active year for acquiring shares with 8 total transactions. John Mendlein's most active month to acquire stocks was the month of May. 2004 was John Mendlein's most active year for disposing of shares, totalling 4 transactions. John Mendlein's most active month to dispose stocks was the month of November. 2023 saw John Mendlein paying a total of $737,130.06 for 239,719 shares, this is the most they've acquired in one year. In 2022 John Mendlein cashed out on 64,488 shares for a total of $1,136,285.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Moderna, Inc. (MRNA) Snapshot price: $72.23
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Omega Therapeutics, Inc. (OMGA) Snapshot price: $1.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FATE THERAPEUTICS INC (FATE) Snapshot price: $3.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +10.07% | 28.46K |
$1.37 | $38,991.57 | 311.23K |
Jan 19
| |||
Form 4
| +78.87% | 124.68K |
$5.60 | $698,138.49 | 282.77K |
Jan 11 - Jan 13
| |||
Form 4
| +5.47% | 8.65K |
—
|
—
| 166.74K |
Jun 9
| |||
Form 4
| -0.86% | -1.36K |
$22.79 | -$31,085.56 | 158.09K |
Jun 3
| |||
Form 4
|
—
|
0
|
$18.33 | -$1,053,753.95 | 159.46K |
Scheduled
|
Mar 10
| ||
Form 4
| +1.71% | 2.68K |
—
|
—
| 159.46K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +11.90% | 16.67K |
$6.00 | $100,002.00 | 156.77K |
Oct 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
aTYR PHARMA INC (LIFE) No price found
CEO and Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
| +66.15% | 245K |
$0.42 | $103,247.00 | 615.38K |
Dec 20 - Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +11.43% | 37.74K |
$2.65 | $100,000.40 | 367.88K |
Aug 31
| |||
Form 4
| +0.04% | 124 |
$3.00 | $372.00 | 327.65K |
Scheduled
|
Apr 24
| ||
Form 4
| +0.79% | 2.55K |
$3.00 | $7,656.00 | 327.52K |
Scheduled
|
Apr 18 - Apr 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +26.96% | 69K |
$2.20 | $151,662.00 | 324.97K |
Dec 19
| |||
Form 4
| +1.01% | 2.5K |
$3.52 | $8,800.00 | 250.97K |
Apr 5
| |||
Form 4
| +1.02% | 2.5K |
$3.55 | $8,875.00 | 248.47K |
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
| +10.84% | 24.05K |
—
|
—
| 245.97K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||